SCHEMBL9525882

SCHEMBL9525882

NS(=O)(=O)c1cnc2ccccn12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.46
TNF P01375 1/20 0.45
ADORA3 P0DMS8 1/20 0.44
IGF1R P08069 1/20 0.44
CDK2 P24941 1/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MIF P14174 1/20 0.43
FLT3 P36888 1/20 0.42
PKM P14618 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 1/20 0.41
GGPS1 O95749 1/20 0.40
FDPS P14324 1/20 0.40
DRD2 P14416 3/20 0.39
HTR2A P28223 3/20 0.39
HTR7 P34969 3/20 0.39
HTR6 P50406 3/20 0.39
EPHB3 P54753 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3155189 0.82 ADORA3 (0.44) ADORA3NPSR1MIFFLT3PKM
SCHEMBL25703657 0.82 FLT3 (0.46) ADORA3NPSR1MIFFLT3PKM
SCHEMBL792707 0.82 ADORA3 (0.44) ADORA3IGF1RCDK2NPSR1MIF
SCHEMBL24803763 0.79 ADORA3 (0.42) ADORA3NPSR1MIFFLT3NPC1
SCHEMBL9075915 0.77 EPHB3 (0.41) ADORA3NPSR1MIFPKMNPC1
SCHEMBL20478464 0.75 CDK8 (0.46) TGFBR1TNFADORA3IGF1RCDK2
SCHEMBL21808337 0.73 HTR2A (0.42) ADORA3CDK2NPSR1FLT3NPC1
SCHEMBL21083345 0.72 TGFBR1 (0.53) TGFBR1TNFHTR6KDM4EALDH1A1
SCHEMBL21084307 0.72 TGFBR1 (0.47) TGFBR1TNFCDK2FLT3
SCHEMBL4557281 0.71 AKR1B1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436955-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS Lario Therapeutics Limited (GB) 2024-10-02 EP disclosed
CN-118317950-A Sulfonamide compounds for the treatment of neurological disorders 拉里奥治疗有限公司 2024-07-09 CN disclosed
WO-2023094830-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS LARIO THERAPEUTICS LIMITED (GB) 2023-06-01 WO disclosed
EP-0574418-A1 ARYL SULPHONYL UREA COMPOUNDS, A METHOD OF PREPARING THEM, AND THEIR USE AS HERBICIDES AND GROWTH REGULATORS Hoechst Schering AgrEvo GmbH (DE) 1993-12-22 EP disclosed
WO-1992013845-A1 ARYL SULPHONYL UREA COMPOUNDS, A METHOD OF PREPARING THEM, AND THEIR USE AS HERBICIDES AND GROWTH REGULATORS HOECHST AKTIENGESELLSCHAFT (DE) 1992-08-20 WO disclosed